SCHEMBL20677260

SCHEMBL20677260

NC(=O)OCCOCCOCCOCCOCCNC(=O)CN1C(=O)C=CC1=O

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MGLL Q99685 1/20 0.40
▸ LMNA P02545 3/20 0.39
▸ PKM P14618 2/20 0.39
▸ GSK3A P49840 1/20 0.39
▸ GSK3B P49841 1/20 0.39
▸ CA2 P00918 5/20 0.35
▸ CA1 P00915 3/20 0.35
▸ CA9 Q16790 3/20 0.35
▸ CA12 O43570 2/20 0.35
▸ CA4 P22748 2/20 0.35
▸ CA14 Q9ULX7 2/20 0.35
▸ SMN1; SMN2 Q16637 2/20 0.35
▸ ALDH1A1 P00352 2/20 0.34
▸ POLB P06746 1/20 0.34
▸ NPC1 O15118 1/20 0.34
▸ CYP1A2 P05177 1/20 0.33
▸ HPGD P15428 1/20 0.33
▸ CYP2C19 P33261 1/20 0.33
▸ BLM P54132 1/20 0.33
▸ WRN Q14191 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13541914 0.88 LMNA (0.47) MGLLLMNAPKMGSK3AGSK3B
SCHEMBL17841834 0.86 MGLL (0.42) MGLLLMNAPKMGSK3AGSK3B
SCHEMBL24797605 0.86 MGLL (0.42) MGLLLMNAPKMGSK3AGSK3B
SCHEMBL24798072 0.86 MGLL (0.42) MGLLLMNAPKMGSK3AGSK3B
SCHEMBL17841923 0.86 MGLL (0.42) MGLLLMNAPKMGSK3AGSK3B
SCHEMBL24797571 0.84 MGLL (0.43) MGLLLMNAPKMGSK3AGSK3B
SCHEMBL24255821 0.84 MGLL (0.43) MGLLLMNAPKMGSK3AGSK3B
SCHEMBL22311942 0.84 MGLL (0.43) MGLLLMNAPKMGSK3AGSK3B
SCHEMBL29398497 0.84 LMNA (0.42) MGLLLMNAPKMGSK3AGSK3B
SCHEMBL24797572 0.84 MGLL (0.43) MGLLLMNAPKMGSK3AGSK3B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3432934-A1 PRODRUGS OF CYTOTOXIC ACTIVE AGENTS HAVING ENZYMATICALLY CLEAVABLE GROUPS Bayer Pharma Aktiengesellschaft (DE) 2019-01-30 — — EP disclosed
Send feedback